Frankthetank - what a great find - thanks for sharing -...

Frankthetank - what a great find - thanks for sharing - Viralytics is in elite company here.

I couple of quick takeaway messages - we all know that combination therapy is the way of the future. One of the articles discusses a  1,000 patient trial just completed concluded
"an international clinical trial involving close to a thousand patients show that combining the immunotherapy drugs ipilimumab and nivolumab results in more powerful responses against advanced melanoma than either drug by itself."
However
"Another important finding is that people who received both drugs reported more-severe side effects — compared with those receiving either drug on its own. "

Biggest thing CAVATAK has going for it is its safety profile - the safest of all potential treatments - why would not everyone want to try CAVATAK in combination.

If I was a big pharma I would be interested in CAVATAK and now I would be getting worried one of my competitors will do a deal unless I move quickly.